Your new post is loading...
Tumor-specific immunotherapy holds the promise of eradicating malignant tumors with exquisite precision without additional toxicity to standard treatments.
Via Krishan Maggon
|
Rescooped by Gilbert C FAURE from Cancer Immunotherapy Review and Collection |
Scoop.it!
Via Krishan Maggon
Review
Bridging infectious disease vaccines with cancer immunotherapy: a role for targeted RNA based immunotherapeuticsElias J Sayour12, Luis Sanchez-Perez3, Catherine Flores1 and Duane A Mitchell1*
*Corresponding author: Duane A Mitchellduane.mitchell@neurosurgery.ufl.edu
Author Affiliations
1Department of Neurosurgery, UF Brain Tumor Immunotherapy Program, University of Florida, Gainesville, Fl, USA
2Department of Pathology, Duke University Medical Center, Durham, NC, USA
3Division of Neurosurgery, Department of Surgery, Duke Brain Tumor Immunotherapy Program, Duke University Medical Center, Durham, NC, USA
For all author emails, please log on.
Journal for Immunotherapy of Cancer 2015, 3:13 doi:10.1186/s40425-015-0058-0